Details of a world-first wireless-operated implant to control the release of therapies have emerged. It's hoped the device will herald a new era for patients reliant on regular and precise doses of molecules that have limited stability, or are very potent.

Publishing in Nature Biotechnology, researchers at biotech start-up MicroCHIPS worked with MIT professors to actively control 100 tiny reservoirs on the cookie-sized implant containing solid, liquid or gel drugs. The reservoirs are capped with a platinum-titanium membrane that erodes in response to an electrical current. The rest of the system comprises off the shelf wireless components and a custom software suite.

Johns Hopkins University neurosurgeon Dr. Henry Brem, who has experimented with the technology to treat brain tumors in rats told AP it was showing great promise.

The plan now is to identify a range of "difficult to deliver" drugs that could exploit the technology. Insulin-dependent diabetics would represent a huge potential cash cow for MicroCHIPS. Human trials for the device are pencilled in within five years. ®

Related stories

• Nutt plots downfall of booze (12 April 2006)
• Final drug trial victim out of the woods (5 April 2006)
• Raver chomps through 40,000 disco biscuits (4 April 2006)
• Friends and families deal with drug trial fallout (16 March 2006)
• UK drugs trial hospitalises six (15 March 2006)
• Net gene tests dismissed as 'snakeoil' (30 January 2006)
• GP budgets reveal map of chronic disease (2 September 2005)
• US getting fatter, faster (25 August 2005)
• Congress seeks stem cell side-step (17 February 2005)
• Berkeley scientists develop bionic chip (28 February 2000)
• Carry your DNA on a smartcard (16 September 1999)